Assessment of Emotion-regulation Skills in Game-based Situations

Sponsor
Babes-Bolyai University (Other)
Overall Status
Completed
CT.gov ID
NCT04788901
Collaborator
The Executive Agency for Higher Education, Research, Development and Innovation Funding (Other)
110
1
1
8.9
12.4

Study Details

Study Description

Brief Summary

The aim of the study is to investigate the validity of in-game scores as indicators for emotional regulation abilities in children and adolescence.

Condition or Disease Intervention/Treatment Phase
  • Other: REThink therapeutic game
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
110 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
The Validity of In-game Performance Measurements or Scores as Indicators of Children's Emotional Regulation Abilities
Actual Study Start Date :
May 5, 2021
Actual Primary Completion Date :
Jan 15, 2022
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Online therapeutic game

Participants in this group will have access to the evaluation module of the REThink game.

Other: REThink therapeutic game
REThink is a online therapeutic game developed by David and collaborators (2018), proved to be an efficient intervention to reduce emotional symptoms of children and adolescents.

Outcome Measures

Primary Outcome Measures

  1. Emotion-regulation [Pre-intervention (one day before the intervention)]

    The Emotion Regulation Index for Children and Adolescents (ERICA; Biesecker & Easterbrooks, 2001). It is a 13-item on a five-point Likert scale, from 0 "strong disagreement" to 5"strong agreement" where higher scores represent better emotional regulation abilities,

  2. Strengths and difficulties [Pre-intervention (one day before the intervention)]

    Strengths and Difficulties Questionnaire - child version (SDQ; Goodman, 1997). It is a 25-item on a three-point Liker scale, from 0 "not true" to 2 "certainly true" where lower scores represent an improvement or lack of problems.

  3. Emotional symptoms [Pre-intervention (one day before the intervention)]

    The Child Behavior Checklist for ages 6-18 (CBCL; Achenbach & Rescorla, 2001) is a parent-report of child emotional and behavioral problems. Each item is rated on a 3-point Likert-style scale ranging from 0 (not true) to 2 (very true or often true). The DSM-derived affective and anxiety scales and the anxious/depressed and withdrawn/depressed syndrome scales, respectively, will be used to assess emotional symptoms.

  4. Emotion recognition [Pre-intervention (one day before the intervention)]

    The Emotion Awareness Questionnaire (EAQ, Rieffe et al., 2008) is a 32-item questionnaire on a three-point Liker scale, from 0 "not true" to 2 "certainly true".

  5. Compassion [Pre-intervention (one day before the intervention)]

    Compassion Scale for Children (CSC, Nas & Sak, 2020) is a 20-items scale rated on a five points Likert scale from "Never" to "Always" where higher scores means higher levels of compassion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • children and adolescents between 8 and 16 years

  • provided written parental consent

Exclusion Criteria:
  • Intellectual disability or physical limitations precluded the use of the computer program

  • Had a major mental health disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Babes-Bolyai University Cluj-Napoca Cluj Romania 400540

Sponsors and Collaborators

  • Babes-Bolyai University
  • The Executive Agency for Higher Education, Research, Development and Innovation Funding

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oana David, Associate Professor, Babes-Bolyai University
ClinicalTrials.gov Identifier:
NCT04788901
Other Study ID Numbers:
  • 1693/22.02.2021
First Posted:
Mar 9, 2021
Last Update Posted:
Aug 19, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Oana David, Associate Professor, Babes-Bolyai University

Study Results

No Results Posted as of Aug 19, 2022